SEC Form 4 · accession 0001127602-15-014566

THERMO FISHER SCIENTIFIC INC. · TMO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Senior Vice President

Period of report

Apr 13, 2015

Accepted (ET)

Apr 15, 2015 · 5:17 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000097745

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Apr 13, 2015	M	2,150	$49.49	A	62,764	D
Common Stock	Apr 13, 2015	M	8,450	$54.97	A	71,214	D
Common Stock	Apr 13, 2015	M	1,825	$49.49	A	73,039	D
Common Stock^F2	Apr 13, 2015	S	12,425	$133.50	D	60,614	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	D/I
Stock Option (Right to Buy)^F3	$49.49	Apr 13, 2015	M	2,150	D	Mar 5, 2011	Mar 5, 2017	Common Stock	2,150	D
Stock Option (Right to Buy)^F4	$54.97	Apr 13, 2015	M	8,450	D	—	Feb 23, 2018	Common Stock	8,450	D
Stock Option (Right to Buy)^F5	$49.49	Apr 13, 2015	M	1,825	D	Mar 5, 2012	Mar 5, 2017	Common Stock	1,825	D

F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2015.
F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $133.29 to $133.88, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3The option vested in four equal installments on March 5, 2011, 2012, 2013 and 2014.
F4The option vested in four equal installments on February 23, 2012, 2013, 2014 and 2015.
F5The option vested in four equal installments on March 5, 2012, 2013, 2014 and 2015.